electroCore, Inc. (ECOR): Capital Expenditures

Annual figures by period end, from SEC filings.

$66.0K
Year ended 2025-12-31
$10.0K
Trailing 12 months to 2026-06-30
$278.9K2017-12-31: $152.5K2018-12-31: $278.9K2019-12-31: $69.7K2023-12-31: $206.0K2025-12-31: $66.0K$66.0K
2017-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$66.0Kn/a2026-03-19, From 2025-01-01
No annual figure between 2023-12-31 and 2025-12-31.
2023-12-31$206.0Kn/a2025-03-12, From 2023-01-01
No annual figure between 2019-12-31 and 2023-12-31.
2019-12-31$69.7K-75.0%2021-03-11, From 2019-01-01
2018-12-31$278.9K+82.9%2020-03-30, From 2018-01-01
2017-12-31$152.5Kn/a2019-03-28, From 2017-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
electroCore, Inc. (ECOR)2025-12-31$66.0Kn/a
Stereotaxis, Inc. (STXS)2025-12-31$93.0K+173.5%
Precision Optics Corporation, Inc. (POCI)2026-06-30$426.8K+87.8%
Iridex Corp (IRIX)2026-01-03$143.0K+1000.0%
QT Imaging Holdings, Inc. (QTI)2025-12-31$124.0K+40.9%
Electromed, Inc. (ELMD)2026-06-30$1.25M+377.9%
Hyperfine, Inc. (HYPR)2025-12-31$1.19M+209.4%
CapsoVision, Inc (CV)2025-12-31$90.0K-41.2%
Escalon Medical Corp (ESMC)2026-06-30$4.4K+13.9%

Compare ECOR, STXS, POCI, IRIX side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗